These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22439000)

  • 1. Rapid susceptibility testing and microcolony analysis of Candida spp. cultured and imaged on porous aluminum oxide.
    Ingham CJ; Boonstra S; Levels S; de Lange M; Meis JF; Schneeberger PM
    PLoS One; 2012; 7(3):e33818. PubMed ID: 22439000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microcolony imaging of Aspergillus fumigatus treated with echinocandins reveals both fungistatic and fungicidal activities.
    Ingham CJ; Schneeberger PM
    PLoS One; 2012; 7(4):e35478. PubMed ID: 22536390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species.
    Chryssanthou E; Cuenca-Estrella M
    J Clin Microbiol; 2002 Oct; 40(10):3841-4. PubMed ID: 12354895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
    Dannaoui E; Paugam A; Develoux M; Chochillon C; Matheron J; Datry A; Bouges-Michel C; Bonnal C; Dromer F; Bretagne S
    Clin Microbiol Infect; 2010 Jul; 16(7):863-9. PubMed ID: 19778296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.
    Pfaller MA; Castanheira M; Messer SA; Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):198-204. PubMed ID: 24736096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibility.
    Eraso E; Ruesga M; Villar-Vidal M; Carrillo-Muñoz AJ; Espinel-Ingroff A; Quindós G
    Rev Iberoam Micol; 2008 Mar; 25(1):3-6. PubMed ID: 18338919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients.
    Morace G; Borghi E; Iatta R; Amato G; Andreoni S; Brigante G; Farina C; Lo Cascio G; Lombardi G; Manso E; Mussap M; Pecile P; Rigoli R; Tangorra E; Valmarin M; Montagna MT
    BMC Infect Dis; 2011 May; 11():130. PubMed ID: 21586108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria.
    Beyer R; Spettel K; Zeller I; Lass-Flörl C; Achleitner D; Krause R; Apfalter P; Buzina W; Strauss J; Gregori C; Schüller C; Willinger B
    Mycoses; 2019 Apr; 62(4):357-367. PubMed ID: 30636016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
    Cretella D; Barber KE; King ST; Stover KR
    J Med Microbiol; 2016 Dec; 65(12):1445-1451. PubMed ID: 27902377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on in vitro susceptibility of Candida spp. isolated from blood culture].
    Grandesso S; Sapino B; Mazzuccato S; Solinas M; Bedin M; D'Angelo M; Gion M
    Infez Med; 2012 Mar; 20(1):25-30. PubMed ID: 22475657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry.
    Pina-Vaz C; Costa-de-Oliveira S; Rodrigues AG; Espinel-Ingroff A
    J Clin Microbiol; 2005 Sep; 43(9):4674-9. PubMed ID: 16145125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
    Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.